Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib(Pancreatic Cancer Action Network), Lynn M. Matrisian(Pancreatic Cancer Action Network), Allison Rosenzweig(Pancreatic Cancer Action Network), Benjamin D. Smith(The University of Texas MD Anderson Cancer Center), Julie Fleshman(Pancreatic Cancer Action Network), Rhonda Aizenberg(Pancreatic Cancer Action Network)
Cited by 7,246
Related Papers
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The matrix‐degrading metalloproteinases
|BioEssays|1992|1.4k
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k